Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lingdancao granules for seasonal influenza
ChiCTR-IPR-15007322Phase 3Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of laggera pterodonta in seasonal influenza (3 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Time to alleviation of all influenza symptoms. Planned start Jul 2015; status: not yet recruiting.
02
Drugs
laggera pterodonta
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on ChiCTR-IPR-15007322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007322.